MIRA Pharmaceuticals Inc.

MIRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.88

$0 (+0.11%)

Sep 22, 2026, 2:40 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $36.94M

Enterprise Value $32.75M

Beta 1.54

Average Volume 433.29K

Shares Outstanding (Diluted) 42.02M

Shares Change YoY 147.39%

Institutional Ownership 5.12%

Exchange NASDAQ

ISIN US60458C1045

Price Performance

Price Change 1M 11.5%

Price Change 3M -8.8%

Price Change 6M -22.3%

Price Change YTD -41.6%

Price Change 1Y -34.6%

Price Change 3Y -80.3%

Price Change 5Y -86.1%

1M CAGR (ann.) 18.8%

1Y CAGR (ann.) -30.8%

5Y CAGR (ann.) N/A

All-Time CAGR -47.3%

Valuation

PE Ratio -0.63

Forward PE N/A

PEG Ratio 0.00

Forward PEG -0.02

PS Ratio N/A

Forward PS 0.90

PB Ratio 4.45

P/FCF Ratio -7.84

P/Adj. FCF Ratio -3.78

P/OCF Ratio -7.91

EV/Sales N/A

EV/EBIT -3.96

EV/EBITDA -3.96

EV/FCF -7.06

Earnings Yield -158.6%

FCF Yield -12.8%

Adj. FCF Yield -26.4%

Financial Health

Net Cash $3.61M

Total Debt $0

Cash & Short-Term Investments $3.61M

Total Assets $8.2M

Current Ratio 200.08

Quick Ratio 200.08

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 533.60

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -107.1%

Returns

Return on Assets -115.6%

Return on Equity -107.0%

Return on Invested Capital -115.2%

Return on Capital Employed -115.2%

Return on Tangible Assets -115.6%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -30.4%

EPS CAGR 5Y -38.7%

EPS CAGR 10Y N/A

FCF CAGR 3Y 10.6%

FCF CAGR 5Y -15.0%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 28.7%

Revenue Growth Next 3Y N/A

Earnings Date Dec 1, 2026

EPS Estimate (next Q) -$0.03

EPS Growth Est (next Q) -97.5%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-4.64M

Free Cash Flow $-4.64M

Adj. Free Cash Flow $-9.61M

FCF Per Share -$0.11

OCF Per Share -$0.11

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-8.25M

EBITDA $-8.27M

Net Income $-9.48M

EPS (Diluted) -$1.38

Revenue / Employee N/A

Profit / Employee $-4.74M

Employees 2